The Role of Chemotherapy in the Management of Celomic Epithelial Carcinoma of the Ovary
- 1 January 1997
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 15 (3) , 277-287
- https://doi.org/10.3109/07357909709039727
Abstract
(1997). The Role of Chemotherapy in the Management of Celomic Epithelial Carcinoma of the Ovary. Cancer Investigation: Vol. 15, No. 3, pp. 277-287. doi: 10.3109/07357909709039727Keywords
This publication has 27 references indexed in Scilit:
- Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.Journal of Clinical Oncology, 1994
- Alcman's Partheneion: Legend and Choral CeremonyThe Classical Quarterly, 1994
- Surgical staging and cytoreductive surgery of epithelial ovarian cancerCancer, 1993
- Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian CancerNew England Journal of Medicine, 1990
- Cyclophosphamide-Cisplatin Versus Cyclophosphamide-Carboplatin in Stage III-IV Ovarian Carcinoma: A Comparison of Equally Myelosuppressive RegimensJNCI Journal of the National Cancer Institute, 1989
- Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study.Journal of Clinical Oncology, 1989
- Carboplatin in combination therapy for ovarian cancerCancer Treatment Reviews, 1988
- A randomized study of cyclophosphamide and cis-platinum with or without doxorubicin in advanced ovarian carcinomaGynecologic Oncology, 1987
- AnnouncementGynecologic Oncology, 1986
- Single agent chemotherapy in the management of ovarian carcinomaPublished by Springer Nature ,1985